Skip to content
Turkey Tail (Trametes Versicolor) and HPV: What the Papilocare Gel Studies Show
Turkey Tail (Trametes Versicolor) and HPV: What the Papilocare Gel Studies Show

Turkey Tail (Trametes Versicolor) and HPV: What the Papilocare Gel Studies Show

Published:9 min readTrametes Versicolor

Can turkey tail mushroom help clear HPV? Not in any way that's proven. The research people quote is mostly about a vaginal gel, sold as Papilocare, that contains a turkey tail (Coriolus versicolor) extract alongside several other ingredients. In its one randomised trial, 91 women with low-grade cervical changes were more likely to have a normal smear after six months with the gel than with watchful waiting (Serrano 2021). But in 2026, the international gynaecology bodies FIGO and IGCS concluded that no topical agent, including this gel, has high-quality evidence of benefit, and they don't endorse routine use (Pareja 2026). This article explains what the studies found and what they don't show.

Turkey tail (Trametes versicolor, also called Coriolus versicolor) has been studied for HPV in two forms. The main one is a multi-ingredient vaginal gel, Papilocare. In an open-label randomised trial of 91 HPV-positive women with low-grade cervical changes, 84.9% had a normal smear and colposcopy at six months with the gel versus 64.5% with watchful waiting, and HPV cleared in 59.6% versus 41.9% (Serrano 2021). However, a 2026 FIGO/IGCS statement found the evidence too weak to endorse any topical HPV treatment and said surveillance remains standard care (Pareja 2026). Oral turkey tail has only one small, preliminary study, in oral HPV (Donatini 2014). No study shows that eating turkey tail clears cervical HPV.

This article is general information, not medical advice. HPV and abnormal smear results should be managed by a doctor or gynaecologist. Don't delay screening, follow-up or recommended treatment in favour of a supplement or gel. HPV vaccination remains the most effective way to prevent the high-risk types.

What Is HPV, and Why Is There Interest in Turkey Tail?

Human papillomavirus (HPV) is a very common sexually transmitted virus. Most infections clear on their own within one to two years. Persistent infection with high-risk types can cause changes in cervical cells that, over many years, may progress to cancer. That's why screening and follow-up matter.

For women with low-grade changes, the usual approach is watchful waiting with repeat tests, because many changes regress without treatment. That gap, a positive result with no treatment to take, is where products like Coriolus-based gels have found a market.

Turkey tail has attracted interest because its polysaccharides, PSK and PSP, affect the immune system. Our article on PSK, PSP and immune modulation explains that research. Lab findings about immunity, though, don't show that turkey tail clears a viral infection in people.

What Is Papilocare?

Papilocare is a vaginal gel marketed for women with HPV and low-grade cervical changes. Its studies describe it as a multi-ingredient, Coriolus versicolor-based gel (Cortés Bordoy 2023). As well as turkey tail extract, it contains other ingredients intended to support the vaginal lining and its natural environment.

That detail matters. Because the gel contains several active ingredients, its results can't be credited to turkey tail alone. And because it's applied directly to the cervix and vagina, its results say nothing about turkey tail taken by mouth.

It's also not one of our products. We sell turkey tail as a food and supplement, not as a treatment for HPV or cervical changes.

What Did the PALOMA Trial Find?

PALOMA is the only randomised trial of the gel. It was multicentre and open-label, meaning patients and doctors knew who received treatment. It compared the gel with watchful waiting in 91 HPV-positive women with low-grade smear changes (Serrano 2021).

  • Cervical changes. At three and six months, 78.0% and 84.9% of treated women had a normal smear and colposcopy, compared with 54.8% and 64.5% without treatment.
  • HPV clearance. At six months, HPV was no longer detected in 59.6% of treated women versus 41.9% without treatment, with a larger gap for high-risk types (62.5% vs 40.0%).
  • Side effects. Seven possible or probable treatment-related adverse events were reported, mostly mild or moderate.

These are encouraging numbers, but note how often the condition improved without treatment: about two-thirds of untreated women had a normal result at six months. That's typical of low-grade changes, and it's why trials need careful design.

What Do Reviews and Gynaecology Bodies Say?

Opinions differ sharply. A 2026 scoping review found five studies of the gel: one randomised trial, a sub-analysis of it and three observational cohorts. Regression rates were 76.1–84.9% in treated women and 40.8–64.5% in untreated controls, with no serious adverse events. The authors called the efficacy "promising but preliminary" and asked for larger, long-term trials (Højen 2026).

The international federation of gynaecology and obstetrics (FIGO) and the International Gynecologic Cancer Society (IGCS) were more critical. Their 2026 statement found that studies of topical HPV treatments had small samples, short follow-up, weak comparators and relied on surrogate measures such as HPV non-detection rather than the prevention of high-grade lesions (Pareja 2026).

For the Coriolus-based gel specifically, they flagged retrospective trial registration and industry funding. They concluded that FIGO and IGCS don't endorse routine use of any currently available topical agent for high-risk HPV or low-grade lesions, and that evidence-based surveillance remains the standard of care (Pareja 2026).

Did Results Differ in Women Over 40?

A sub-analysis of the PALOMA trial looked at 41 women older than 40, with an average age of about 48. After six months, 92.3% of treated women had a normal smear and colposcopy, compared with 50.0% of those who were monitored. HPV cleared in 61.5% of treated women versus 50.0% of controls, and the clearance difference wasn't reported as significant (Gil-Antuñano 2022).

For the highest-risk types, HPV 16, 18 and 31, normal results were seen in 75.0% versus 40.0%, but the groups were so small that the difference wasn't statistically significant (Gil-Antuñano 2022). A sub-analysis of 41 women can suggest where to look next, but it can't settle the question on its own.

It's also worth noting what none of these studies measured: whether the gel prevents high-grade lesions or cancer over several years. That's the outcome FIGO and IGCS say future trials should use (Pareja 2026).

Is There Evidence for Taking Turkey Tail by Mouth?

Very little. The only clinical study we found of oral turkey tail and HPV was a small, preliminary French study in oral, not cervical, HPV. Among 61 people with gingivitis who tested positive for HPV16 or HPV18 in mouth swabs, 41 took turkey tail combined with reishi and 20 took a different mushroom for two months. Clearance was 88% in the turkey tail and reishi group and 5% in the comparison group (Donatini 2014).

That sounds striking, but the study was small and the authors called it preliminary. It combined two mushrooms, so turkey tail's own role is unclear. It hasn't been repeated, and it says nothing about cervical HPV.

So there's no good evidence that turkey tail capsules, tea or powder clear cervical HPV. Turkey tail's stronger human research is in cancer care, where the extract PSK has been used alongside standard treatment; our article on turkey tail in oncology covers that evidence.

What Should You Do After a Positive HPV Test?

Follow your screening programme. For most people with HPV and low-grade changes, that means repeat testing at the interval your doctor recommends. Many infections and changes clear on their own, as the untreated groups in the gel studies show.

  • Keep every follow-up appointment. The point of surveillance is to catch the small number of changes that progress.
  • Ask about vaccination. HPV vaccines prevent infection with the main high-risk types, and your doctor can advise whether it's useful for you.
  • Don't smoke. Smoking is linked to persistent HPV infection and cervical disease.
  • Discuss any product with your doctor. If you're considering a gel or supplement, talk it through rather than using it instead of follow-up.

If you're interested in turkey tail for general wellbeing, our guides to turkey tail dosage and turkey tail side effects and interactions explain how it's used. Our dried turkey tail is sold as a food and supplement, not as a treatment for HPV.

Frequently Asked Questions

Does turkey tail cure HPV?

No. There's no good evidence that turkey tail taken by mouth clears cervical HPV. The studies people cite are mainly of a multi-ingredient vaginal gel, and gynaecology bodies don't endorse it for routine use.

What is Papilocare?

A multi-ingredient vaginal gel containing a Coriolus versicolor (turkey tail) extract and other ingredients. In one open-label trial of 91 women, more had normal results at six months than with watchful waiting.

Is the Coriolus vaginal gel recommended?

Not by FIGO and IGCS. Their 2026 statement found the evidence for topical HPV treatments too weak and said surveillance remains the standard of care.

Can turkey tail capsules help with HPV?

There's no trial of turkey tail capsules for cervical HPV. One small, preliminary study combined turkey tail and reishi for oral HPV, and it hasn't been repeated.

Does HPV go away on its own?

Often, yes. Most HPV infections clear within one to two years. In the gel trial, about two-thirds of untreated women had a normal result at six months. Keep up with follow-up tests.

Related Articles

Sources

  1. Serrano L, López AC, González SP, Palacios S, Dexeus D, Centeno-Mediavilla C, et al. Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women With Human Papillomavirus-Dependent Cervical Lesions: The PALOMA Study. J Low Genit Tract Dis. 2021;25(2):130-136. PubMed 33746195
  2. Pareja R, Heredia F, Sánchez-Díaz E, Cuello MA, de Sanjosé S, Jerónimo J, et al. FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions. Int J Gynaecol Obstet. 2026;175(1):18-25. PubMed 42677467
  3. Højen IB, Kristensen MK, Bertelsen VM, Tranberg M, Petersen LK, Andersen B, et al. Effect of coriolus versicolor-based vaginal gel on clearance of human papillomavirus and cervical dysplasia - a scoping review. BMC Womens Health. 2026;26(1):71. PubMed 41507892
  4. Cortés Bordoy J, de Santiago García J, Agenjo González M, Dexeus Carter D, Fiol Ruiz G, García Ferreiro C, et al. Effect of a Multi-Ingredient Coriolus-versicolor-Based Vaginal Gel in Women with HPV-Dependent Cervical Lesions: The Papilobs Real-Life Prospective Study. Cancers (Basel). 2023;15(15). PubMed 37568678
  5. Donatini B. Control of oral human papillomavirus (HPV) by medicinal mushrooms, Trametes versicolor and Ganoderma lucidum: a preliminary clinical trial. Int J Med Mushrooms. 2014;16(5):497-8. PubMed 25271984
  6. Gil-Antuñano SP, Serrano Cogollor L, López Díaz AC, González Rodríguez SP, Dexeus Carter D, Centeno Mediavilla C, et al. Efficacy of a Coriolusversicolor-Based Vaginal Gel in Human Papillomavirus-Positive Women Older Than 40 Years: A Sub-Analysis of PALOMA Study. J Pers Med. 2022;12(10). PubMed 36294699
Last updated:

If you found this post helpful, don't forget to share it with your friends and colleagues.